Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liu, Kai ^a   Zhang, Yan ^a   Hu, Shizong ^a   Yu, Yang ^a   Yang, Qianting ^b   Jin, Dongdong ^a   Chen, Xinchun ^b   Jin, Qi ^a   Liu, Haiying ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA;

ADULT; ARTICLE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INFECTION; LUNG TUBERCULOSIS; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PLEURA EFFUSION; POPULATION RESEARCH; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUBERCULOUS PLEURISY; UPREGULATION;

ADOLESCENT; ADULT; B-CELL ACTIVATING FACTOR; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; YOUNG ADULT;

EID: 84862189937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038429     Document Type: Article

References (42)

1. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
2. Kaufmann SH, McMichael AJ, (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11: S33-44.
3. Young DB, Gideon HP, Wilkinson RJ, (2009) Eliminating latent tuberculosis. Trends Microbiol 17: 183-188.
4. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
5. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
6. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613-621.
7. Homolka S, Niemann S, Russell DG, Rohde KH, (2010) Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog 6: e1000988.
8. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, et al. (2008) Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS One 3: e1403.
9. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
10. Flynn JL, Chan J, (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
11. Chen X, Yang Q, Zhang M, Graner M, Zhu X, et al. (2009) Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 16: 879-884.
12. Chen X, Zhang M, Liao M, Graner MW, Wu C, et al. (2010) Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells. Am J Respir Crit Care Med 181: 734-742.
13. Reiner A, Yekutieli D, Benjamini Y, (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375.
14. Budak F, Uzaslan EK, Cangur S, Goral G, Oral HB, (2008) Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 186: 337-343.
15. Ng LG, Mackay CR, Mackay F, (2005) The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 42: 763-772.
16. Daridon C, Youinou P, Pers JO, (2008) BAFF, APRIL, TWE-PRIL: who's who? Autoimmun Rev 7: 267-271.
17. Mackay F, Schneider P, Rennert P, Browning J, (2003) BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21: 231-264.
18. Crouser ED, Culver DA, Knox KS, Julian MW, Shao G, et al. (2009) Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 179: 929-938.
19. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, et al. (2008) Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 177: 402-411.
20. Kaufmann SH, (2001) How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 1: 20-30.
21. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104.
22. Hanekom WA, Hussey GD, Hughes EJ, Potgieter S, Yogev R, et al. (1999) Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy. Clin Diagn Lab Immunol 6: 204-208.
23. Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, et al. (1998) Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 160: 5448-5454.
24. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, et al. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103: 679-688.
25. Chu VT, Enghard P, Schurer S, Steinhauser G, Rudolph B, et al. (2009) Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 60: 2083-2093.
26. Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, et al. (2005) BAFF augments certain Th1-associated inflammatory responses. J Immunol 174: 5537-5544.
27. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, et al. (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173: 807-817.
28. Huard B, Schneider P, Mauri D, Tschopp J, French LE, (2001) T cell costimulation by the TNF ligand BAFF. J Immunol 167: 6225-6231.
29. Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, et al. (2010) Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 207: 1757-1773.
30. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, et al. (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3: 822-829.
31. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, et al. (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97: 198-204.
32. Craxton A, Magaletti D, Ryan EJ, Clark EA, (2003) Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
33. Liu Y, Xu L, Opalka N, Kappler J, Shu HB, et al. (2002) Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108: 383-394.
34. Huard B, Arlettaz L, Ambrose C, Kindler V, Mauri D, et al. (2004) BAFF production by antigen-presenting cells provides T cell co-stimulation. Int Immunol 16: 467-475.
35. Rahman ZS, Manser T, (2004) B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J Immunol 173: 6179-6188.
36. Dempsey PW, Doyle SE, He JQ, Cheng G, (2003) The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14: 193-209.
37. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243-2247.
38. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
39. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
40. Alcais A, Fieschi C, Abel L, Casanova JL, (2005) Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 202: 1617-1621.
41. Jouanguy E, Doffinger R, Dupuis S, Pallier A, Altare F, et al. (1999) IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 11: 346-351.
42. Dillon SR, Gross JA, Ansell SM, Novak AJ, (2006) An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5: 235-246.